Govt prescribes faster access to medicines for rare diseases

India is streamlining access to rare disease drugs by waiving local clinical trials for some medications. The drug regulator is expediting approvals, facilitating imports, and prioritizing testing to ensure faster availability for patients. This includes fast-tracking global trial approvals and waiving trials for certain advanced therapies and drugs used in pandemics or for defence.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/yX4wMpD
via IFTTT